Deal kneads knee imaging

Perceptive Informatics has allied with Optasia Medical to enhance its medical imaging capabilities for osteoarthritis clinical trials. The e-clinical solutions provider is using Optasia's KneeAnalyzer software to supplement its existing medical-imaging technology in an effort to improve reproducibility and hasten image analysis of the knee in osteoarthritis patients.

The Optasia Platform uses model-based vision technology to detect, measure, classify and compare 2-D medical images. Medical imaging aids in the early evaluation of drug candidates for musculoskeletal-related clinical research, including rheumatoid arthritis, osteoporosis, and osteoarthritis, according to an announcement. The alliance is intended to improve surrogate measurements in trials focused on knee-related osteoarthritis.

Perceptive Informatics announced in July that it had joined with Biospective in a deal to enhance processing and analysis of medical images for central nervous system and oncology-related clinical trials, as reported earlier. 

- here's the announcement
- see our earlier coverage

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.